SUNDAY, FEBRUARY 15
AFTERNOON COURSES | 2:00 – 5:00 pm
SC1: Translating CTCs to Clinical Use - Detailed Agenda
Joshua M. Lang, M.D., MS, Assistant Professor of Medicine, Carbone Cancer Center, University of Wisconsin, Wisconsin Institutes for Medical Research
Allison Welsh, Ph.D., CTC Scientist, Foundation Medicine, Inc.
Benjamin Casavant, Ph.D., Vice President, Tasso
SC2: Latest Advances in Molecular Pathology - Detailed Agenda
Michael H.A. Roehrl, M.D., Ph.D., Director, UHN Program in BioSpecimen Sciences, University of Toronto
Xu Li, M.D., Ph.D., Director, Cytogenetics Lab, Genetics, Kasier Permanente San Jose Medical Center
Carlos J Suarez, M.D., Assistant Professor, Pathology, Molecular Pathology, Stanford University Medical Center, Stanford Health Care
SC3: Validation and Compliance Considerations for an NGS Lab - Detailed Agenda
Victoria M. Pratt, Ph.D., FACMG, Director, Pharmacogenomics Laboratory, Medical and Molecular Genetics, Indiana University School of Medicine
Monica J. Basehore, Ph.D., FACMG, Lead Director, Molecular Diagnostic Laboratory; Associate Director, Medical Genetics Training Program, Greenwood Genetic Center
SC4: Sequencing 101 - Detailed Agenda
Ryan Kim, Ph.D., Director, UC Davis Genome Center, DNA Technologies and Expression Analysis Cores, University of California, Davis
SC5: PCR Part I: Primer Design for PCR Experiments - Detailed Agenda
Jian Han, Ph.D., Faculty Investigator, iCubate, HudsonAlpha Institute for Biotechnology
Carl T. Wittwer, M.D., Ph.D., Professor, Pathology, University of Utah
SC6: Reimbursement for Advanced Diagnostics: From Clinical Value Establishment to Coverage and Pricing - Detailed Agenda
Catherine Schnabel, Ph.D., Senior Vice President, Research & Development, bioTheranostics, Inc.
Macey Johnson III, Vice President, Managed Care and Reimbursement, bioTheranostics, Inc.
DINNER COURSES | 5:30 – 8:30 pm
SC9: Clinical Informatics Needs of an NGS Lab - Detailed Agenda
Alexis B. Carter, M.D., Assistant Professor, Pathology and Laboratory Medicine; Member, Center for Comprehensive Informatics; Director, Pathology Informatics, Emory University School of Medicine; Chair, AMP Informatics Interest Group; President, Association of Pathology Informatics
Federico A. Monzon, M.D., FCAP, Director, Oncology, InVitae; Adjunct Faculty, Baylor College of Medicine
Mark J. Routbort, M.D., Ph.D., Director, Computational and Integrational Pathology; Associate Professor, Hematopathology; Medical Director, Laboratory Informatics, UT MD Anderson Cancer Center
SC10: Knowing Your NGS Analysis Upstream: Alignments and Variants - Detailed Agenda
Gabe Rudy, Vice President, Product and Engineering, Golden Helix
SC11: Regulatory Compliance in Molecular Diagnostics - Detailed Agenda
Pamela L. Swatkowski, Director, Regulatory Affairs, Abbott Molecular, Inc.
Melina Cimler, Ph.D.,Senior Vice President, Quality & Regulatory, Adaptive Biotechnologies
Maham Ansari, MS, RAC, Senior Manager, Regulatory Affairs, Focal Healthcare, Inc.
SC12: Introduction to Hadoop for Bioinformatics - Detailed Agenda
Martin Gollery, CEO, Tahoe Informatics
SC13: PCR Part II: Digital PCR Applications and Advances - Detailed Agenda
Alison Devonshire, Ph.D., Science Leader, Nucleic Acid Metrology, LGC Genomics
Robert Palais, Ph.D., Associate Professor, Math Dept, Utah Valley University; Research Professor, Pathology Dept, University of Utah
MONDAY, FEBRUARY 16
MORNING COURSES | 8 – 11:00 am
SC17: Commercialization Boot Camp: Manual for Success in Molecular Diagnostics - Detailed Agenda
Harry Glorikian, Healthcare Consultant
Elaine Cheung, Business & Corporate Development, Illumina
SC18: Next-Generation Sequencing as a Diagnostics Platform - Detailed Agenda
Karl Voelkerding, M.D., Professor of Pathology, University of Utah; Medical Director, Genoomics and Bioinformatics, ARUP Laboratories
Jennifer Morrissette, Ph.D., Scientific Director, Clinical Cytogenetics Laboratory; Clinical Director, Center for Personalized Diagnostics (CPD), University of Pennsylvania School of Medicine
SC19: Isolation and Characterization of Cancer Stem Cells
Leslie Crews, Ph.D., Assistant Project Scientist, Catriona Jamieson Laboratory, Sanford Consortium for Regenerative Medicine and MooresUCSD Cancer Center
Kristen M. Smith, Ph.D., Scientist II, Bionomics, Inc.
SC20: Using PreFSC12clinical Models in Oncology to Inform First-Man-Trial Design: Tools and Techniques
- Detailed Agenda
Arijit Chakravarty, Ph.D., Director, Modeling & Simulation (DMPK), Takeda Pharmaceutical International Co.
SC21: Best Practices in Personalized and Translational Medicine - Detailed Agenda
Erik Bierwagen, Principal Programmer Analyst, Genentech
Sergio Rotstein, Ph.D., Director, Research Business Technology, Pfizer, Inc.
Jean Yuan, Senior Programming Analyst, Genentech
Doug Garrett, Software Engineer, Genentech
SC22: NGS for Infectious Disease Diagnostics - Detailed Agenda
Charles Chiu, M.D., Ph.D., Assistant Professor, Lab Medicine and Medicine, Infectious Diseases, University of California San Francisco
* Separate Registration Require or All Access Registration.